The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi

BACKGROUND: Trials of BCG vaccination to prevent or reduce severity of COVID-19 are taking place in adults, some of whom have been previously vaccinated, but evidence of the beneficial, non-specific effects of BCG come largely from data on mortality in infants and young children, and from in-vitro a...

Descripción completa

Detalles Bibliográficos
Autores principales: Glynn, Judith R, Dube, Albert, Fielding, Katherine, Crampin, Amelia C, Kanjala, Chifundo, Fine, Paul E M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550897/
https://www.ncbi.nlm.nih.gov/pubmed/34237262
http://dx.doi.org/10.1016/S1473-3099(20)30994-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550897/
https://www.ncbi.nlm.nih.gov/pubmed/34237262
http://dx.doi.org/10.1016/S1473-3099(20)30994-4

Ejemplares similares